Loading clinical trials...
Loading clinical trials...
The aim of this study is to predict the length of intensive care unit stay of patients treated in a tertiary general intensive care unit with the help of the Braden risk assesment scale, which is used...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ankara City Hospital Bilkent
NCT06605144 · Intensive Care Unit ICU, Vasopressor, and more
NCT07234201 · Intensive Care Unit ICU
NCT07179705 · Intradialytic Hypotension, Intensive Care Unit ICU, and more
NCT06692400 · Intensive Care Unit ICU, Intubation, and more
NCT06683781 · Mechanical Ventilation, Weaning Failure, and more
Ankara Bilkent City Hospital
Ankara
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions